NEW YORK (GenomeWeb News) – Rosetta Genomics said today that it has licensed non-exclusive rights to microRNA genes for research applications from Rockefeller University.
The agreement covers viral and human microRNAs that Rosetta intends to add to its existing intellectual property portfolio, which currently includes two issued patents, two allowed patent applications, and 60 pending patent applications. The Rehovot, Israel-based firm previously licensed from Rockefeller rights to microRNAs for therapeutic and diagnostic uses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.